


Healthcare Industry NewsFeed
HSMN NewsFeed - 5 Mar 2018
U.S. FDA Accepts New Drug Application for Prucalopride (SHP555) for Chronic Idiopathic Constipation
U.S. FDA Accepts New Drug Application for Prucalopride (SHP555) for Chronic Idiopathic Constipation
HSMN NewsFeed - 5 Mar 2018
Philips introduces next generation of IntelliSpace Cardiovascular informatics platform at HIMSS 2018
Philips introduces next generation of IntelliSpace Cardiovascular informatics platform at HIMSS 2018
HSMN NewsFeed - 2 Mar 2018
Mylan to Introduce Two New Cost-Saving HIV Combination Treatments in the U.S.
Mylan to Introduce Two New Cost-Saving HIV Combination Treatments in the U.S.
HSMN NewsFeed - 2 Mar 2018
FDA to Review DUPIXENT(R) (dupilumab) as Potential Treatment for Moderate-to-Severe Asthma
FDA to Review DUPIXENT(R) (dupilumab) as Potential Treatment for Moderate-to-Severe Asthma
HSMN NewsFeed - 28 Feb 2018
Successful First in Human for OrthoSpin's Robotic External Orthopedic Fixation System
Successful First in Human for OrthoSpin's Robotic External Orthopedic Fixation System
HSMN NewsFeed - 28 Feb 2018
Poseida Therapeutics Appoints Mark Gergen as Chief Business Officer and Chief Financial Officer
Poseida Therapeutics Appoints Mark Gergen as Chief Business Officer and Chief Financial Officer
HSMN NewsFeed - 28 Feb 2018
SnoreRx, Now Available at CVS, is First and Only FDA Certified Non-prescription Anti Snoring Treatment
SnoreRx, Now Available at CVS, is First and Only FDA Certified Non-prescription Anti Snoring Treatment
HSMN NewsFeed - 27 Feb 2018
VitalConnect Launches Continuous Patient Monitoring Platform in Hospitals Nationwide
VitalConnect Launches Continuous Patient Monitoring Platform in Hospitals Nationwide
HSMN NewsFeed - 27 Feb 2018
Amgen Receives Positive CHMP Opinion For Delivery System Of Neulasta(R) (pegfilgrastim)
Amgen Receives Positive CHMP Opinion For Delivery System Of Neulasta(R) (pegfilgrastim)
HSMN NewsFeed - 27 Feb 2018
Abbott and Surmodics Announce Agreement for Next-Generation Drug-Coated Balloon
Abbott and Surmodics Announce Agreement for Next-Generation Drug-Coated Balloon
HSMN NewsFeed - 27 Feb 2018
Senti Biosciences Secures $53 Million Series A to Build the Future of Gene and Cell-Based Therapies
Senti Biosciences Secures $53 Million Series A to Build the Future of Gene and Cell-Based Therapies
HSMN NewsFeed - 26 Feb 2018
Integra LifeSciences Appoints Sravan Emany as Vice President, Treasurer and Investor Relations
Integra LifeSciences Appoints Sravan Emany as Vice President, Treasurer and Investor Relations
HSMN NewsFeed - 26 Feb 2018
GigaGen Announces Appointment of Jan Fredrik Simons, Ph.D., as Senior Director, Technology
GigaGen Announces Appointment of Jan Fredrik Simons, Ph.D., as Senior Director, Technology
HSMN NewsFeed - 23 Feb 2018
Vascular Graft Solutions: External Stenting of Vein Grafts is Associated With High Early Patency Rates
Vascular Graft Solutions: External Stenting of Vein Grafts is Associated With High Early Patency Rates
HSMN NewsFeed - 23 Feb 2018
Mallinckrodt Receives FDA Acceptance of Stannsoporfin New Drug Application Filing
Mallinckrodt Receives FDA Acceptance of Stannsoporfin New Drug Application Filing
HSMN NewsFeed - 22 Feb 2018
GenomeDx Announces Inclusion of Decipher Genomic Testing in NCCN Guidelines for Prostate Cancer
GenomeDx Announces Inclusion of Decipher Genomic Testing in NCCN Guidelines for Prostate Cancer
HSMN NewsFeed - 22 Feb 2018
Kallyope Inc. Announces $66M Series B Financing to Advance Programs Targeting the Gut-Brain Axis
Kallyope Inc. Announces $66M Series B Financing to Advance Programs Targeting the Gut-Brain Axis
HSMN NewsFeed - 21 Feb 2018
Medtronic Introduces MiniMed(TM) Mio(TM) Advance Infusion Set for People with Diabetes
Medtronic Introduces MiniMed(TM) Mio(TM) Advance Infusion Set for People with Diabetes
HSMN NewsFeed - 21 Feb 2018
Amneal Introduces Memantine Hydrochloride Extended-Release Capsules, Generic for Namenda XR(R)
Amneal Introduces Memantine Hydrochloride Extended-Release Capsules, Generic for Namenda XR(R)
HSMN NewsFeed - 21 Feb 2018
Pharmaceutical Startup, Bridge Therapeutics, Names David H. Bergstrom, Ph.D. as New Chief Operating Officer
Pharmaceutical Startup, Bridge Therapeutics, Names David H. Bergstrom, Ph.D. as New Chief Operating Officer
HSMN NewsFeed - 20 Feb 2018
Peritech Pharma's Novel Hemorrhoids Treatment Commercialized in 24 Countries
Peritech Pharma's Novel Hemorrhoids Treatment Commercialized in 24 Countries
